These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 20957337)
21. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949 [TBL] [Abstract][Full Text] [Related]
22. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells. Liu N; Hu G; Wang H; Li Z; Guo Z J Cell Mol Med; 2018 Nov; 22(11):5300-5310. PubMed ID: 30133120 [TBL] [Abstract][Full Text] [Related]
23. Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells. Uchida H; Arita K; Yunoue S; Yonezawa H; Shinsato Y; Kawano H; Hirano H; Hanaya R; Tokimura H J Neurooncol; 2011 Sep; 104(3):697-704. PubMed ID: 21380601 [TBL] [Abstract][Full Text] [Related]
24. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma. Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma. Liu XY; Zhang L; Wu J; Zhou L; Ren YJ; Yang WQ; Ming ZJ; Chen B; Wang J; Zhang Y; Yang JM PLoS One; 2013; 8(11):e81345. PubMed ID: 24303044 [TBL] [Abstract][Full Text] [Related]
26. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression. Perazzoli G; Prados J; Ortiz R; Caba O; Cabeza L; Berdasco M; Gónzalez B; Melguizo C PLoS One; 2015; 10(10):e0140131. PubMed ID: 26447477 [TBL] [Abstract][Full Text] [Related]
27. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863 [TBL] [Abstract][Full Text] [Related]
28. Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level. Gong A; Ge N; Yao W; Lu L; Liang H Cancer Chemother Pharmacol; 2014 Sep; 74(3):531-8. PubMed ID: 25047724 [TBL] [Abstract][Full Text] [Related]
29. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis. Deng Y; Zhu H; Xiao L; Liu C; Meng X Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781 [TBL] [Abstract][Full Text] [Related]
30. High expression of leptin receptor leads to temozolomide resistance with exhibiting stem/progenitor cell features in gliobalastoma. Han G; Wang L; Zhao W; Yue Z; Zhao R; Li Y; Zhou X; Hu X; Liu J Cell Cycle; 2013 Dec; 12(24):3833-40. PubMed ID: 24131927 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression. Wu Y; Yao Y; Yun Y; Wang M; Zhu R Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31409725 [TBL] [Abstract][Full Text] [Related]
32. Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. Oliva CR; Nozell SE; Diers A; McClugage SG; Sarkaria JN; Markert JM; Darley-Usmar VM; Bailey SM; Gillespie GY; Landar A; Griguer CE J Biol Chem; 2010 Dec; 285(51):39759-67. PubMed ID: 20870728 [TBL] [Abstract][Full Text] [Related]
33. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide. Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells. Ohba S; Hirose Y; Kawase T; Sano H J Neurooncol; 2009 Dec; 95(3):307-316. PubMed ID: 19517066 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide. Kanzawa T; Germano IM; Kondo Y; Ito H; Kyo S; Kondo S Br J Cancer; 2003 Sep; 89(5):922-9. PubMed ID: 12942127 [TBL] [Abstract][Full Text] [Related]
36. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death. Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811 [TBL] [Abstract][Full Text] [Related]
37. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma. Han B; Meng X; Wu P; Li Z; Li S; Zhang Y; Zha C; Ye Q; Jiang C; Cai J; Jiang T Theranostics; 2020; 10(7):3351-3365. PubMed ID: 32194873 [No Abstract] [Full Text] [Related]
38. Preliminary Study on Relationship Between Temozolomide Chemotherapy-Resistant Cells and Stem Cells in Gliomas. Min X; Dingchao X; Xun Z; Cunzu W Turk Neurosurg; 2022; 32(3):357-363. PubMed ID: 35615767 [TBL] [Abstract][Full Text] [Related]
39. Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2. Zhu D; Tu M; Zeng B; Cai L; Zheng W; Su Z; Yu Z Cancer Med; 2017 Feb; 6(2):452-462. PubMed ID: 28064447 [TBL] [Abstract][Full Text] [Related]
40. The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells. Hayashi T; Adachi K; Ohba S; Hirose Y J Neurooncol; 2013 Nov; 115(2):169-78. PubMed ID: 23943501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]